Teresa Rossi

3PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 08, 2026
BET inhibition unmasks a targetable glycolytic dependency through a HIF1α stabilization and driven transcriptional program in a defined subset of triple-negative breast Cancer.

|Sep 03, 2024
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells.

Teresa Rossi, Egidio Iorio, Mattea Chirico

|Oct 19, 2023
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Benedetta Donati, Francesca Reggiani, Federica Torricelli

Pageof 1

Frequent Collaborators

2 joint publications

Mariaelena Pistoni

2 joint publications

Alessia Ciarrocchi

1 joint publications

Benedetta Donati

1 joint publications

Francesca Reggiani